<?xml version='1.0' encoding='utf-8'?>
<document id="25603031"><sentence text="Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1∗15 and OATP1B3." /><sentence text="Human organic anion-transporting polypeptide 1B1 (OATP1B1) and OATP1B3 are important hepatic uptake transporters" /><sentence text=" Early assessment of OATP1B1/1B3-mediated drug-drug interactions (DDIs) is therefore important for successful drug development" /><sentence text=" A promising approach for early screening and prediction of DDIs is computational modeling" /><sentence text=" In this study we aimed to generate a rapid, single Bayesian prediction model for OATP1B1, OATP1B1∗15 and OATP1B3 inhibition" /><sentence text=" Besides our previously generated HEK-OATP1B1 and HEK-OATP1B1∗15 cells, we now generated and characterized HEK-OATP1B3 cells" /><sentence text=" Using these cell lines we investigated the inhibitory potential of 640 FDA-approved drugs from a commercial library (10μM) on the uptake of [(3)H]-estradiol-17β-d-glucuronide (1μM) by OATP1B1, OATP1B1∗15, and OATP1B3"><entity charOffset="141-175" id="DDI-PubMed.25603031.s7.e0" text="[(3)H]-estradiol-17β-d-glucuronide" /><entity charOffset="185-192" id="DDI-PubMed.25603031.s7.e1" text="OATP1B1" /><entity charOffset="194-204" id="DDI-PubMed.25603031.s7.e2" text="OATP1B1∗15" /><pair ddi="false" e1="DDI-PubMed.25603031.s7.e0" e2="DDI-PubMed.25603031.s7.e0" /><pair ddi="false" e1="DDI-PubMed.25603031.s7.e0" e2="DDI-PubMed.25603031.s7.e1" /><pair ddi="false" e1="DDI-PubMed.25603031.s7.e0" e2="DDI-PubMed.25603031.s7.e2" /><pair ddi="false" e1="DDI-PubMed.25603031.s7.e1" e2="DDI-PubMed.25603031.s7.e1" /><pair ddi="false" e1="DDI-PubMed.25603031.s7.e1" e2="DDI-PubMed.25603031.s7.e2" /></sentence><sentence text=" Using a cut-off of ⩾60% inhibition, 8% and 7% of the 640 drugs were potent OATP1B1 and OATP1B1∗15 inhibitors, respectively" /><sentence text=" Only 1% of the tested drugs significantly inhibited OATP1B3, which was not sufficient for Bayesian modeling" /><sentence text=" Modeling of OATP1B1 and OATP1B1∗15 inhibition revealed that presence of conjugated systems and (hetero)cycles with acceptor/donor atoms in- or outside the ring enhance the probability of a molecule binding these transporters" /><sentence text=" The overall performance of the model for OATP1B1 and OATP1B1∗15 was ⩾80%, including evaluation with a true external test set" /><sentence text=" Our Bayesian classification model thus represents a fast, inexpensive and robust means of assessing potential binding of new chemical entities to OATP1B1 and OATP1B1∗15" /><sentence text=" As such, this model may be used to rank compounds early in the drug development process, helping to avoid adverse effects in a later stage due to inhibition of OATP1B1 and/or OATP1B1∗15" /><sentence text=" " /></document>